[go: up one dir, main page]

CL2016000082A1 - Ciclodextrinas. - Google Patents

Ciclodextrinas.

Info

Publication number
CL2016000082A1
CL2016000082A1 CL2016000082A CL2016000082A CL2016000082A1 CL 2016000082 A1 CL2016000082 A1 CL 2016000082A1 CL 2016000082 A CL2016000082 A CL 2016000082A CL 2016000082 A CL2016000082 A CL 2016000082A CL 2016000082 A1 CL2016000082 A1 CL 2016000082A1
Authority
CL
Chile
Prior art keywords
cyclodextrine
cyclodextrins
activated
contact
eter
Prior art date
Application number
CL2016000082A
Other languages
English (en)
Inventor
Tammy Savage
Stephen Wicks
John Mitchell
Original Assignee
Curadev Pharma Pvt Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49081370&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2016000082(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Curadev Pharma Pvt Ltd filed Critical Curadev Pharma Pvt Ltd
Publication of CL2016000082A1 publication Critical patent/CL2016000082A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/16—Cyclodextrin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

METODO PARA PREPARAR UNA SULFOALQUIL ETER-BETA-CICLODEXTRINA QUE COMPRENDE PONER EN CONTACTO UNA CICLODEXTRINA CON UNA BASE PARA FORMAR UNA CICLODEXTRINA ACTIVADA, Y LUEGO PONER EN CONTACTO LA CICLODEXTRINA ACTIVADA CON UNA ALQUIL SULTONA.
CL2016000082A 2013-07-17 2016-01-14 Ciclodextrinas. CL2016000082A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361847509P 2013-07-17 2013-07-17
GBGB1312737.8A GB201312737D0 (en) 2013-07-17 2013-07-17 Cyclodextrin

Publications (1)

Publication Number Publication Date
CL2016000082A1 true CL2016000082A1 (es) 2016-09-23

Family

ID=49081370

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016000082A CL2016000082A1 (es) 2013-07-17 2016-01-14 Ciclodextrinas.

Country Status (14)

Country Link
US (2) US11117978B2 (es)
EP (1) EP3022231B1 (es)
JP (1) JP2016525600A (es)
KR (1) KR20160031019A (es)
CN (1) CN105431458A (es)
AP (1) AP2016008975A0 (es)
AU (1) AU2014291800A1 (es)
CA (1) CA2919501A1 (es)
CL (1) CL2016000082A1 (es)
GB (3) GB201312737D0 (es)
HU (1) HUE038911T2 (es)
MX (1) MX2016000553A (es)
PT (1) PT3022231T (es)
WO (1) WO2015008066A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
WO2018140856A1 (en) 2017-01-30 2018-08-02 Bio-Rad Laboratories, Inc. Emulsion compositions and methods of their use
US11274164B2 (en) 2017-02-07 2022-03-15 Biophore India Pharmaceuticals Pvt. Ltd. Method for the preparation of sulfobutylether beta cyclodextrin sodium
CN112370451A (zh) * 2020-12-08 2021-02-19 河北科技大学 一种枸橼酸马罗匹坦包合物、注射液及制备方法
CN112557541B (zh) * 2020-12-08 2022-07-12 河北科技大学 一种枸橼酸马罗匹坦及其有关物质的检测方法
CN114369177A (zh) * 2021-12-31 2022-04-19 贵州省欣紫鸿药用辅料有限公司 一种采用管道反应器制备磺丁基醚-β-环糊精的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
KR0166088B1 (ko) * 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5874418A (en) * 1997-05-05 1999-02-23 Cydex, Inc. Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use
GB9713149D0 (en) 1997-06-21 1997-08-27 Pfizer Ltd Pharmaceutical formulations
DE69834154T2 (de) * 1997-07-01 2007-01-25 Pfizer Products Inc., Groton Verfahren zur Herstellung von einem Cyclodextrin
US6337380B1 (en) * 1998-12-01 2002-01-08 Fuji Photo Film Co., Ltd. Polymer having sulfonic acid group and silver halide photographic photosensitive material using the polymer
US6869939B2 (en) 2002-05-04 2005-03-22 Cydex, Inc. Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
CN100503647C (zh) * 2005-11-02 2009-06-24 南京师范大学 羟丙基-磺丁基-β-环糊精及其制备方法、分析方法以及在药学上的应用
WO2008134600A1 (en) * 2007-04-27 2008-11-06 Cydex Pharmaceuticals, Inc. Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
US7635773B2 (en) 2008-04-28 2009-12-22 Cydex Pharmaceuticals, Inc. Sulfoalkyl ether cyclodextrin compositions
HUE058834T2 (hu) * 2012-02-15 2022-09-28 Cydex Pharmaceuticals Inc Elõállítási eljárás ciklodextrin-származékokhoz
TWI603737B (zh) 2012-05-08 2017-11-01 歐尼克斯治療公司 用於調配胜肽蛋白酶體抑制劑的環糊精錯合法

Also Published As

Publication number Publication date
GB2519832A (en) 2015-05-06
WO2015008066A1 (en) 2015-01-22
CA2919501A1 (en) 2015-01-22
MX2016000553A (es) 2016-08-01
GB2586104A (en) 2021-02-03
PT3022231T (pt) 2018-06-11
GB202015609D0 (en) 2020-11-18
CN105431458A (zh) 2016-03-23
GB2519832B (en) 2021-03-03
US10239961B2 (en) 2019-03-26
US20160024229A1 (en) 2016-01-28
AU2014291800A1 (en) 2016-02-11
GB201312737D0 (en) 2013-08-28
JP2016525600A (ja) 2016-08-25
US11117978B2 (en) 2021-09-14
EP3022231B1 (en) 2018-04-18
EP3022231A1 (en) 2016-05-25
GB201412644D0 (en) 2014-08-27
HUE038911T2 (hu) 2018-12-28
US20150025023A1 (en) 2015-01-22
KR20160031019A (ko) 2016-03-21
AP2016008975A0 (en) 2016-01-31
GB2586104B (en) 2021-03-31

Similar Documents

Publication Publication Date Title
CL2016000082A1 (es) Ciclodextrinas.
MX2018009876A (es) Encapsulamiento y desencapsulamiento de medios.
IN2013KO01336A (es)
MX2015015239A (es) Composiciones y metodos.
CR20130614S (es) Pared lateral de neumático
HUE054788T2 (hu) Lyukasztótüskék, hozzátartozó perselyek és eljárások perselyek kialakítására felhasználva lyukasztótüskéket
FR3014746B1 (fr) Bande de roulement evolutive pour pneu.
TWD160462S (zh) 電磁閥
TWD160463S (zh) 電磁閥
CL2013002626A1 (es) Artículo para fumar que comprende una primera parte y una segunda parte movil en relacion con la primera parte, y ademas un mecanismo de control que comprende una primera superficie de control y una segunda superficie de control; metodo de fabricacion del articulo para fumar.
EP3059259A4 (en) TERMINAL CONJUGATED CONJUGATED DIENE CONDUCTIVE POLYMER AND PROCESS FOR PRODUCING THE SAME
EP3073513A4 (en) Structure-manufacturing method using step-and-repeat imprinting technique
TWD159828S (zh) 連接器
UA116372C2 (uk) Частинки резинату фенілефрину
MX2015015003A (es) Caja de ingletes.
DK3061597T3 (da) Dækreparationsmaskine.
CL2015001302A1 (es) Metodo de preparacion de 2-alquil-1,2-bencisotiazolin-3-onas.
RU2013136122A (ru) Способ получения борированных порфиринов
FR3001837B1 (fr) Piece de support de cable, notamment pour aeronef.
TH1401005790B (th) วิธีการผลิตองค์ประกอบพอลิเมธิลอลูมินอกเซน (polymethyl aluminoxane) สภาพของแข็งที่มีขนาดเส้นผ่าศูนย์กลางอนุภาคเล็ก
TH1401007108B (th) ลำตัวโครงสร้างเบ้ารับตัวหน่วงการสั่นสะเทือนและวิธีการผลิตลำตัวโครงสร้างเบ้ารับตัวหน่วงการสั่นสะเทือน
TH1401007283B (th) โครงสร้างสำหรับต่อประกบ, ชิ้นส่วนประกอบสำหรับต่อประกบซึ่งมีโครงสร้างสำหรับต่อประกบและวิธีการผลิตชิ้นส่วนประกอบสำหรับต่อประกบซึ่งมีโครงสร้างสำหรับต่อประกบ
CL2012002622A1 (es) Procedimiento para preparar una composicion farmaceutica que comprende i) proporcionar una primera combinacion que comprende a) un compuesto b) una o mas ciclodextrinas y c) agua, ii) poner en contacto la primera combinacion con un acido para formar una segunda combinacion; composicion farmaceutica.
TH1401005802B (th) ชุดชิ้นส่วนประกอบของก้านกระทุ้งลูกสูบ, กระบอกสูบหลักและวิธีการผลิตสำหรับชุดชิ้นส่วนประกอบของก้านกระทุ้งลูกสูบ
UY34022A (es) Metodo para formar una capa que recubre un suelo, y capa asi formada que recubre un suelo